XWEL
XWELL, Inc.
Healthcare — Diagnostics & Research
XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program; and various services and support, including technical support services and advanced services. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
Price History
Fundamentals
| Market Cap | $9.12M |
| P/E Ratio (TTM) | - |
| Forward P/E | -0.41 |
| EPS (TTM) | $-5.59 |
| Dividend Yield | - |
| Profit Margin | -81.44% |
| Revenue Growth | -5.50% |
| ROE | -333.68% |
| Debt/Equity | 82.50 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 33.3 |
| Beta | 1.01 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $2.20 |
| 52-Week Low | $0.26 |
| 50-Day Avg | $1.26 |
| 200-Day Avg | $0.97 |
| Avg Volume | 135.7K |
| Volume | 369 |
Performance Analysis
BEARISHXWEL is flashing more cautionary signals — investors should monitor closely.
Recent News
Last updated: Jul 02, 2026 13:38 UTC
Back to Screener Export Report